Literature DB >> 4809312

Experimental canine distemper virus-induced lymphoid depletion.

B McCullough, S Krakowka, A Koestner.   

Abstract

Thirty-four gnotobiotic dogs were used to study the effects of R252 canine distemper virus (CDV) infection on the lymphoid system. Twenty-one dogs were inoculated parenterally, and 6 dogs were infected by contact exposure to inoculated littermates. Seven littermate dogs were maintained as uninfected controls. The means of the absolute lymphocyte counts of dogs infected with R252 CDV were significantly decreased for 7 weeks after infection. The lymphocyte counts failed to return to normal in 7 dogs which became moribund with neurologic signs and were sacrificed 27 to 47 days after infection (group I). The 19 dogs which survived the 12-week observation period had normal lymphocyte counts by 8 weeks after infection. Five of these dogs (group II) were subsequently found to have demyelination of the central nervous system (CNS), while no CNS lesions were demonstrated in the remaining 14 infected dogs (group III). The thymuses of dogs of group I were atrophic and their lymph nodes were depleted in lymphoid cells. In addition, the number of Hassall's corpuscles per thymic lobule were decreased in dogs of group I. Viral nucleoprotein was demonstrated in thymus and lymph node cells by electron microscopy. No lymphoid lesions were found in the dogs of group II. Some of the thymuses of dogs of group III were significantly larger than those of uninfected controls, and they contained increased numbers of Hassall's corpuscles per thymic lobule. Further, germinal centers were found in two thymuses of dogs of group III.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4809312      PMCID: PMC1910729     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  Depression of the tuberculin reaction by attenuated measles virus vaccine.

Authors:  W J MELLMAN; R WETTON
Journal:  J Lab Clin Med       Date:  1963-03

2.  The immunodepressive effect of rinderpest virus.

Authors:  W J Penhale; I A Pow
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

3.  Thymolymphatic deficiency and depression of cell-mediated immunity in protein-calorie malnutrition.

Authors:  P M Smythe; G G Brereton-Stiles; H J Grace; A Mafoyane; M Schonland; H M Coovadia; W E Loening; M A Parent; G H Vos
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

4.  Immunodepression by viruses.

Authors:  M H Salaman
Journal:  Antibiot Chemother       Date:  1969

5.  The effect of measles on the thymus and other lymphoid tissues.

Authors:  R G White; J F Boyd
Journal:  Clin Exp Immunol       Date:  1973-03       Impact factor: 4.330

6.  Regneration of thymus, spleen and bone marrow in x-irradiated AKR mice.

Authors:  A Decleve; G B Gerber; A Leonard; M Lambiet-Collier; A Sassen; J R Maisin
Journal:  Radiat Res       Date:  1972-08       Impact factor: 2.841

7.  Pathogenesis of canine distemper.

Authors:  M J Appel
Journal:  Am J Vet Res       Date:  1969-07       Impact factor: 1.156

8.  Blood leukocyte response to live measles vaccine.

Authors:  F L Black; S R Sheridan
Journal:  Am J Dis Child       Date:  1967-03

9.  Effect of adrenalectomy on the lymphoid lesions in dogs with experimentally induced canine distemper.

Authors:  R O Jacoby; R A Griesemer
Journal:  Am J Vet Res       Date:  1970-10       Impact factor: 1.156

10.  Biphasic pattern of thymus regeneration after whole-body irradiation.

Authors:  A Takada; Y Takada; C C Huang; J L Ambrus
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

View more
  18 in total

1.  Canine distemper virus epithelial cell infection is required for clinical disease but not for immunosuppression.

Authors:  Bevan Sawatsky; Xiao-Xiang Wong; Sarah Hinkelmann; Roberto Cattaneo; Veronika von Messling
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Lymphoid cell necrosis, thymic atrophy, and growth retardation in newborn mice inoculated with murine cytomegalovirus.

Authors:  J N Schwartz; C A Daniels; G K Klintworth
Journal:  Am J Pathol       Date:  1975-06       Impact factor: 4.307

3.  Effects of canine distemper virus infection on lymphoid function in vitro and in vivo.

Authors:  S Krakowka; G Cockerell; A Koestner
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

4.  The retrospective use of a peroxidase technique for confirmation of suspected canine distemper in Kenya.

Authors:  P K Gathumbi
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

5.  Demyelination in experimental canine distemper virus infection: immunological, pathologic, and immunohistological studies.

Authors:  M Vandevelde; R J Higgins; B Kristensen; F Kristensen; A J Steck; U Kihm
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

6.  Distemper virus infection in ferrets: an animal model of measles-induced immunosuppression.

Authors:  C A Kauffman; A G Bergman; R P O'Connor
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

7.  Canine distemper virus-associated encephalitis: modification by passive antibody administration.

Authors:  S Krakowka; R A Mador; A Koestner
Journal:  Acta Neuropathol       Date:  1978-09-15       Impact factor: 17.088

8.  Syncytia inhibition by immune lymphocytes: in vitro test for immunity to canine distemper.

Authors:  S Krakowka; A L Wallace; A Koestner
Journal:  J Clin Microbiol       Date:  1978-03       Impact factor: 5.948

9.  Immunological and pathological findings in demyelinating encephalitis associated with canine distemper virus infection.

Authors:  M Vandevelde; F Kristensen; B Kristensen; A J Steck; U Kihm
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

10.  Intracerebral synthesis of antibodies to measles and distemper viruses in patients with subacute sclerosing panencephalitis and multiple sclerosis.

Authors:  N T Gorman; J Habicht; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.